Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Restraint, Physical × 90 days × Clear all

Phase

Status

Recruiting 6 Completed 3 Active not recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1 Neoplasms 1

Interventions

pembrolizumab 34 Nivolumab 12 Carboplatin 10 venetoclax 9 Specimen Handling 9 Biopsy 9 Gemcitabine 8 fludarabine 7 atezolizumab 7 Radiosurgery 7 Pemetrexed 7 Magnetic Resonance Spectroscopy 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Paclitaxel 6 Docetaxel 6 Cyclophosphamide 6 Trastuzumab 5 Interviews as Topic 5 Fulvestrant 5 Drug Therapy 5 tislelizumab 4 binimetinib 4 X-Rays 4 Radiotherapy 4 Radiation 4 Ipilimumab 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡